These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 8090730

  • 1. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice.
    Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H, Bradley A.
    Proc Natl Acad Sci U S A; 1994 Sep 13; 91(19):8817-21. PubMed ID: 8090730
    [Abstract] [Full Text] [Related]

  • 2. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.
    Coerver KA, Woodruff TK, Finegold MJ, Mather J, Bradley A, Matzuk MM.
    Mol Endocrinol; 1996 May 13; 10(5):534-43. PubMed ID: 8732684
    [Abstract] [Full Text] [Related]

  • 3. Follistatin is a modulator of gonadal tumor progression and the activin-induced wasting syndrome in inhibin-deficient mice.
    Cipriano SC, Chen L, Kumar TR, Matzuk MM.
    Endocrinology; 2000 Jul 13; 141(7):2319-27. PubMed ID: 10875231
    [Abstract] [Full Text] [Related]

  • 4. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q, Kumar R, Underwood K, O'Connor AE, Loveland KL, Seehra JS, Matzuk MM.
    Mol Hum Reprod; 2007 Sep 13; 13(9):675-83. PubMed ID: 17704537
    [Abstract] [Full Text] [Related]

  • 5. Role of androgens in testicular tumor development in inhibin-deficient mice.
    Shou W, Woodruff TK, Matzuk MM.
    Endocrinology; 1997 Nov 13; 138(11):5000-5. PubMed ID: 9348231
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.
    Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF, Nilson JH, Hammer GD.
    Mol Cell Biol; 2003 Jun 13; 23(11):3951-64. PubMed ID: 12748296
    [Abstract] [Full Text] [Related]

  • 9. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
    Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM.
    Mol Endocrinol; 1999 Jun 13; 13(6):851-65. PubMed ID: 10379885
    [Abstract] [Full Text] [Related]

  • 10. Activin-βC modulates gonadal, but not adrenal tumorigenesis in the inhibin deficient mice.
    Marino FE, Risbridger G, Gold E.
    Mol Cell Endocrinol; 2015 Jul 05; 409():41-50. PubMed ID: 25869398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T, Matzuk MM, Perlas E, Finegold MJ, Lewis KA, Vale W, Bradley A, Hsueh AJ.
    Mol Endocrinol; 1994 Aug 05; 8(8):983-95. PubMed ID: 7997239
    [Abstract] [Full Text] [Related]

  • 13. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.
    Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ.
    Recent Prog Horm Res; 1996 Aug 05; 51():123-54; discussion 155-7. PubMed ID: 8701077
    [Abstract] [Full Text] [Related]

  • 14. Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.
    Rajanahally S, Agno JE, Nalam RL, Weinstein MB, Loveland KL, Matzuk MM, Li Q.
    Reprod Biol Endocrinol; 2010 Jun 21; 8():69. PubMed ID: 20565978
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Genetic engineering to study testicular tumorigenesis.
    Yan W, Burns KH, Matzuk MM.
    APMIS; 2003 Jan 21; 111(1):174-81; discussion 182-3. PubMed ID: 12760377
    [Abstract] [Full Text] [Related]

  • 18. Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice.
    Wu X, Chen L, Brown CA, Yan C, Matzuk MM.
    Mol Endocrinol; 2004 Jun 21; 18(6):1509-19. PubMed ID: 15016837
    [Abstract] [Full Text] [Related]

  • 19. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene.
    Kananen K, Markkula M, Mikola M, Rainio EM, McNeilly A, Huhtaniemi I.
    Mol Endocrinol; 1996 Dec 21; 10(12):1667-77. PubMed ID: 8961275
    [Abstract] [Full Text] [Related]

  • 20. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
    Marino FE, Risbridger G, Gold E.
    Mol Hum Reprod; 2014 Dec 21; 20(12):1223-37. PubMed ID: 25180271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.